April 17, 2019, 03:28 pm

FDA fast-tracks Intensity Therapeutics' breast cancer treatment

 17-04-2019 3:28 PM

Lewis Bender Westport biotech firm Intensity Therapeutics Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for the development of a treatment for relapsed or metastatic triple negative breast cancer. INT230-6 is comprised of two proven, potent...

Posted in: Tags:
Westfair Online
Westfair Online

This article was posted online by Westfair Online. Spot On Connecticut collects excepts of news articles from this news source and add these in the 'Connecticut Business'-category. For mor einformation about Spot On Connecticut, you can check the About Us-page.

This story was posted in the category: